Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500
收藏DataCite Commons2025-04-16 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00010887/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a phase 1, randomized, double-blind, placebo-controlled, multiple ascending dose study to assess the safety, tolerability, pharmacokinetic (PK), immunogenicity, and pharmacodynamic (PD) effects of REGN1500 in patients with a metabolic disorder.
提供机构：
Vivli
创建时间：
2024-12-12
